Dr Yvonne Lamb to join Norgine as director of global pharmacovigilance
pharmafile | December 8, 2009 | Appointment | Research and Development, Sales and Marketing | Norgine, appointment, research and development, sales and marketing
Norgine has appointed Dr Yvonne Lamb as director, global pharmacovigilance, with effect from January 25 2010.
A qualified physician, Yvonne has extensive industry experience, serving most recently as pharmacovigilance therapy area head for respiratory at GlaxoSmithKline, prior to which she led the firm’s pharmacovigilance therapy area for neurosciences.
In former roles, she worked in medical evaluation at Roche and as UK medical director at Searle.
She also previously led the UK Clinical Development team for SmithKline Beecham, a role that included a period as medical director for Australia.
Related Content
Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …
Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …
Lonza CEO to step down in 2020
It has been announced that Marc Funk, Chief Executive Officer at Lonza, is set to …